| answer text |
<p>The Department convened a roundtable event on 11 February 2015 to discuss what
action, could most expeditiously be taken to ensure that robust evidence about new
uses for existing drugs is produced, disseminated and then used to inform clinical
decision making about these medicines.</p><p> </p><p> </p><p> </p><p>A number of areas
were identified where further work could help improve matters, including:</p><p> </p><p>
</p><p> </p><p>- supporting clinicians to identify the latest robust evidence on patient
care and take it up in their own practice; and</p><p> </p><p>- supporting and mapping
clear pathways for innovators and those who want to "re-purpose" drugs.</p><p>
</p><p> </p><p> </p><p>Officials have since been engaging with stakeholders to progress
outputs associated with this event.</p><p> </p><p> </p><p> </p><p> </p><p> </p>
|
 |
